BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Lymphoma AND NUTM1, NUT, 256646, ENSG00000184507
53 results:

  • 1. Transcriptome Sequencing Allows Comprehensive Genomic Characterization of Pediatric B-Acute Lymphoblastic Leukemia in an Academic Clinical Laboratory.
    Hu Z; Kovach AE; Yellapantula V; Ostrow D; Doan A; Ji J; Schmidt RJ; Gu Z; Bhojwani D; Raca G
    J Mol Diagn; 2024 Jan; 26(1):49-60. PubMed ID: 37981088
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Detection of clinically actionable gene fusions by next-generation sequencing-based RNA sequencing of non-small cell lung cancer cytology specimens: A single-center experience with comparison to fluorescence in situ hybridization.
    Diks J; Tang Z; Altan M; Anderson S; Chen H; Rashid A; Yang RK; Routbort MJ; Patel KP; Toruner GA; Medeiros LJ; Tang G; Luthra R; Roy-Chowdhuri S
    Cancer Cytopathol; 2024 Jan; 132(1):41-49. PubMed ID: 37747438
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Emerging molecular subtypes and therapies in acute lymphoblastic leukemia.
    Davis K; Sheikh T; Aggarwal N
    Semin Diagn Pathol; 2023 May; 40(3):202-215. PubMed ID: 37120350
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Classification and genetics of pediatric B-other acute lymphoblastic leukemia by targeted RNA sequencing.
    Migita NA; Jotta PY; Nascimento NPD; Vasconcelos VS; Centoducatte GL; Massirer KB; Azevedo AC; Brandalise SR; Yunes JA
    Blood Adv; 2023 Jul; 7(13):2957-2971. PubMed ID: 36848637
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Genetic characteristics and treatment outcome in infants with KMT2A germline B-cell precursor acute lymphoblastic leukemia: Results of MLL-Baby protocol.
    Popov A; Tsaur G; Permikin Z; Henze G; Verzhbitskaya T; Plekhanova O; Nokhrina E; Valochnik A; Sibiryakov P; Zerkalenkova E; Olshanskaya Y; Gindina T; Movchan L; Shorikov E; Streneva O; Khlebnikova O; Makarova O; Arakaev O; Boichenko E; Kondratchik K; Ponomareva N; Lapotentova E; Aleinikova O; Miakova N; Novichkova G; Karachunskiy A; Fechina L
    Pediatr Blood Cancer; 2023 Apr; 70(4):e30204. PubMed ID: 36715125
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. The contemporary management of cancers of the sinonasal tract in adults.
    Thawani R; Kim MS; Arastu A; Feng Z; West MT; Taflin NF; Thein KZ; Li R; Geltzeiler M; Lee N; Fuller CD; Grandis JR; Floudas CS; Heinrich MC; Hanna E; Chandra RA
    CA Cancer J Clin; 2023 Jan; 73(1):72-112. PubMed ID: 35916666
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Single-cell transcriptomics reveals a distinct developmental state of KMT2A-rearranged infant B-cell acute lymphoblastic leukemia.
    Khabirova E; Jardine L; Coorens THH; Webb S; Treger TD; Engelbert J; Porter T; Prigmore E; Collord G; Piapi A; Teichmann SA; Inglott S; Williams O; Heidenreich O; Young MD; Straathof K; Bomken S; Bartram J; Haniffa M; Behjati S
    Nat Med; 2022 Apr; 28(4):743-751. PubMed ID: 35288693
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Evidence for Multiple Subpopulations of Herpesvirus-Latently Infected Cells.
    Landis JT; Tuck R; Pan Y; Mosso CN; Eason AB; Moorad R; Marron JS; Dittmer DP
    mBio; 2022 Feb; 13(1):e0347321. PubMed ID: 35089062
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Whole-transcriptome analysis in acute lymphoblastic leukemia: a report from the DFCI ALL Consortium Protocol 16-001.
    Tran TH; Langlois S; Meloche C; Caron M; Saint-Onge P; Rouette A; Bataille AR; Jimenez-Cortes C; Sontag T; Bittencourt H; Laverdière C; Lavallée VP; Leclerc JM; Cole PD; Gennarini LM; Kahn JM; Kelly KM; Michon B; Santiago R; Stevenson KE; Welch JJG; Schroeder KM; Koch V; Cellot S; Silverman LB; Sinnett D
    Blood Adv; 2022 Feb; 6(4):1329-1341. PubMed ID: 34933343
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Intra-, para-, and suprasellar nuclear protein of testis carcinoma with infiltration of cavernous sinus and clivus-a case report.
    Tosic L; Voglis S; Reuss AM; Rushing EJ; Regli L; Serra C
    Acta Neurochir (Wien); 2022 Apr; 164(4):1105-1110. PubMed ID: 34800152
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. [Clinicopathological characteristics of SMARCB1(INI1)-deficient sinonasal carcinoma].
    Wang JY; Bai YP; Xing L; Piao YS; He XJ; Yue CL; Zhao XL; Liu HG
    Zhonghua Bing Li Xue Za Zhi; 2021 Nov; 50(11):1240-1245. PubMed ID: 34719161
    [No Abstract]    [Full Text] [Related]  

  • 12. Genetic characterisation of childhood B-other-acute lymphoblastic leukaemia in UK patients by fluorescence in situ hybridisation and Multiplex Ligation-dependent Probe Amplification.
    Schwab CJ; Murdy D; Butler E; Enshaei A; Winterman E; Cranston RE; Ryan S; Barretta E; Hawking Z; Murray J; Antony G; Vora A; Moorman AV; Harrison CJ
    Br J Haematol; 2022 Feb; 196(3):753-763. PubMed ID: 34676543
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. nut carcinoma of the lung.
    Lantuejoul S; Pissaloux D; Ferretti GR; McLeer A
    Semin Diagn Pathol; 2021 Sep; 38(5):72-82. PubMed ID: 34176698
    [TBL] [Abstract] [Full Text] [Related]  

  • 14.
    Pan R; Wang Z; Wang X; Fang R; Xia Q; Rao Q
    Int J Surg Pathol; 2022 Feb; 30(1):99-105. PubMed ID: 34057377
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Expression of BCL6 in paediatric B-cell acute lymphoblastic leukaemia and association with prognosis.
    Mäkinen A; Nikkilä A; Mehtonen J; Teppo S; Oksa L; Nordlund J; Rounioja S; Pohjolainen V; Laukkanen S; Heinäniemi M; Paavonen T; Lohi O
    Pathology; 2021 Dec; 53(7):875-882. PubMed ID: 34049715
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Emerging molecular subtypes and therapeutic targets in B-cell precursor acute lymphoblastic leukemia.
    Li J; Dai Y; Wu L; Zhang M; Ouyang W; Huang J; Chen S
    Front Med; 2021 Jun; 15(3):347-371. PubMed ID: 33400146
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Clinicopathological Findings of Haematological Malignancies in Hospital Admitted Patients.
    Islam AS; Ara ZG; Bhuiyan GR; Khan AU; Khan MM
    Mymensingh Med J; 2021 Jan; 30(1):28-34. PubMed ID: 33397847
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. A Phase 1 study of RO6870810, a novel bromodomain and extra-terminal protein inhibitor, in patients with nut carcinoma, other solid tumours, or diffuse large B-cell lymphoma.
    Shapiro GI; LoRusso P; Dowlati A; T Do K; Jacobson CA; Vaishampayan U; Weise A; Caimi PF; Eder JP; French CA; Labriola-Tompkins E; Boisserie F; Pierceall WE; Zhi J; Passe S; DeMario M; Kornacker M; Armand P
    Br J Cancer; 2021 Feb; 124(4):744-753. PubMed ID: 33311588
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Emerging entities in nutm1-rearranged neoplasms.
    McEvoy CR; Fox SB; Prall OWJ
    Genes Chromosomes Cancer; 2020 Jun; 59(6):375-385. PubMed ID: 32060986
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. How advanced are we in targeting novel subtypes of ALL?
    Mullighan CG
    Best Pract Res Clin Haematol; 2019 Dec; 32(4):101095. PubMed ID: 31779973
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 3.